Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NTRB
NTRB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NTRB News
Nutriband Annual Meeting Update: New Directors and Product Developments
Jan 30 2026
Newsfilter
Nutriband Sells 90% of Subsidiary for $5M, Enhancing Shareholder Value
Dec 31 2025
Globenewswire
Nutriband Sells 90% of Subsidiary for $5M, Enhancing Shareholder Value
Dec 31 2025
Newsfilter
Nutriband Sells 90% of Subsidiary for $5M, No Dilution for Shareholders
Dec 31 2025
Yahoo Finance
Nutriband Sells 90% Stake in Pocono Pharmaceutical for $5 Million
Dec 29 2025
Benzinga
Nutriband Sells 90% Stake in Pocono Pharmaceutical for $5 Million
Dec 29 2025
NASDAQ.COM
Nutriband Sells 90% Stake in Pocono Pharmaceutical for $5M
Dec 29 2025
Globenewswire
Nutriband Sells 90% Stake in Pocono Pharmaceutical for $5M
Dec 29 2025
Newsfilter
Nutriband Develops First Abuse-Deterrent Fentanyl Patch with Potential US Sales of $200 Million
Dec 18 2025
Newsfilter
Korro Bio, Inc. (KRRO) Announces Q3 Loss and Falls Short of Revenue Projections
Nov 12 2025
NASDAQ.COM
Metagenomi (MGX) Posts Q3 Loss, Falls Short of Revenue Projections
Nov 11 2025
NASDAQ.COM
Nutriband Co-Founder Gareth Sheridan Reassumes Position as CEO
Oct 27 2025
NASDAQ.COM
Nutriband Partners with Brand Institute to Create a Commercial Name for Its Abuse-Resistant Fentanyl Patch
Oct 10 2025
Newsfilter
After-Hours Surge Boosts PALI, HCTI, NTRB, KPTI, EDIT, and CGON Amid Mixed News and Strategic Actions
Oct 10 2025
NASDAQ.COM
Nutriband Inc. Reports Record Q2 2025 Revenue Growth of 50.87% Year-Over-Year and Advances in NDA Filing for AVERSA Fentanyl
Sep 10 2025
Newsfilter
Nutriband Inc. (NTRB) Posts Q2 Loss, Falls Short of Revenue Projections
Sep 10 2025
NASDAQ.COM
Show More News
